EMVision Medical Devices Ltd (EMV.AX)
AUD 1.75
(-6.91%)
AUD 1.75
(-6.91%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -15.7 Million AUD | -126.63% |
| 2023 | -6.92 Million AUD | -14.3% |
| 2022 | -6.06 Million AUD | 36.04% |
| 2021 | -9.47 Million AUD | -75.2% |
| 2020 | -5.4 Million AUD | -23.4% |
| 2019 | -4.38 Million AUD | -330.55% |
| 2018 | -1.01 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -15.7 Million AUD | 0.0% |
| 2024 Q2 | -5.5 Million AUD | 0.0% |
| 2024 FY | -15.7 Million AUD | -126.63% |
| 2023 FY | -6.92 Million AUD | -14.3% |
| 2023 Q2 | -8.94 Million AUD | 0.0% |
| 2023 Q4 | -6.92 Million AUD | 0.0% |
| 2022 FY | -6.06 Million AUD | 36.04% |
| 2022 Q2 | -10.38 Million AUD | 0.0% |
| 2022 Q4 | -6.06 Million AUD | 0.0% |
| 2021 Q2 | -12.75 Million AUD | 0.0% |
| 2021 FY | -9.47 Million AUD | -75.2% |
| 2021 Q4 | -9.47 Million AUD | 0.0% |
| 2020 Q2 | -6.87 Million AUD | 0.0% |
| 2020 FY | -5.4 Million AUD | -23.4% |
| 2020 Q4 | -5.4 Million AUD | 0.0% |
| 2019 Q3 | -4.38 Million AUD | 25.0% |
| 2019 Q2 | -5.84 Million AUD | 0.0% |
| 2019 FY | -4.38 Million AUD | -330.55% |
| 2019 Q4 | -4.38 Million AUD | 0.0% |
| 2018 Q4 | -1.01 Million AUD | 0.0% |
| 2018 FY | -1.01 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 38.392% |
| Adherium Limited | -6.1 Million AUD | -157.214% |
| Aroa Biosurgery Limited | -3.74 Million AUD | -319.018% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -335.743% |
| Anteris Technologies Ltd | -28.49 Million AUD | 44.906% |
| Control Bionics Limited | -19.02 Thousand AUD | -82442.419% |
| CardieX Limited | 2.74 Million AUD | 671.718% |
| Compumedics Limited | 5.08 Million AUD | 408.654% |
| Cochlear Limited | -269.9 Million AUD | 94.183% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 2347.552% |
| Cyclopharm Limited | -7.49 Million AUD | -109.374% |
| Nova Eye Medical Limited | -2.8 Million AUD | -460.358% |
| HeraMED Limited | -799.34 Thousand AUD | -1864.253% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 208.412% |
| ImpediMed Limited | -23.48 Million AUD | 33.155% |
| InhaleRx Limited | -155.54 Thousand AUD | -9994.391% |
| LBT Innovations Limited | -604 Thousand AUD | -2499.54% |
| Micro-X Limited | 826.99 Thousand AUD | 1998.578% |
| Neurotech International Limited | -2.11 Million AUD | -643.964% |
| OncoSil Medical Limited | -4.43 Million AUD | -254.371% |
| PolyNovo Limited | -30.52 Million AUD | 48.566% |
| Respiri Limited | 413.68 Thousand AUD | 3895.416% |
| SomnoMed Limited | -15.16 Million AUD | -3.551% |
| Universal Biosensors, Inc. | -5.3 Million AUD | -196.029% |
| Uscom Limited | -1.53 Million AUD | -925.799% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | -284.556% |